Andrea Pirzkall

Andrea Pirzkall worked as the Chief Medical Director at Genentech, Inc. from 2007 to 2017.
She then worked as the Executive Director-Clinical Development at BeiGene Ltd. from 2017 to 2020.
Prior to that, she was the Director-Clinical Affairs at DxTx Medical, Inc. from 2002 to 2003.
Most recently, she served as the Chief Medical Officer at Replimune Group, Inc. from 2020 to 2021.
Pirzkall earned a doctorate degree from Friedrich Schiller University of Jena.